Léčba roztroušené sklerózy přípravkem 1. linie a těhotenství // SOLEN

Neurológia pre prax 1/2020

Treatment of multiple sclerosis with first-line therapy and prenancy

Teriflunomide is a disease modyfing drug for treatment in multiple sclerosis as one of the options for first-line therapy. It has teratogenic and embyotoxic potential according to animal studies. The data on pregnancy use in women are limited and its use in pregnancy is contraindicated. However, there are cases where women have taken teriflunomide during conception and pregnancy.

Keywords: multiple sclerosis, teriflunomide, pregnancy